Investigations on the 4‐Quinolone‐3‐Carboxylic Acid Motif Part 5: Modulation of the Physicochemical Profile of a Set of Potent and Selective Cannabinoid‐2 Receptor Ligands through a Bioisosteric Approach
- 2 March 2012
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 7 (5), 920-934
- https://doi.org/10.1002/cmdc.201100573
Abstract
Three heterocyclic systems were selected as potential bioisosteres of the amide linker for a series of 1,6‐disubstituted‐4‐quinolone‐3‐carboxamides, which are potent and selective CB2 ligands that exhibit poor water solubility, with the aim of improving their physicochemical profile and also of clarifying properties of importance for amide bond mimicry. Among the newly synthesized compounds, a 1,2,3‐triazole derivative (1‐(adamantan‐1‐yl)‐4‐[6‐(furan‐2‐yl)‐1,4‐dihydro‐4‐oxo‐1‐pentylquinolin‐3‐yl]‐1H‐1,2,3‐triazole) emerged as the most promising in terms of both physicochemical and pharmacodynamic properties. When assayed in vitro, this derivative exhibited inverse agonist activity, whereas, in the formalin test in mice, it produced analgesic effects antagonized by a well‐established inverse agonist. Metabolic studies allowed the identification of a side chain hydroxylated derivative as its only metabolite, which, in its racemic form, still showed appreciable CB2 selectivity, but was 150‐fold less potent than the parent compound.This publication has 73 references indexed in Scilit:
- Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screeningAnalytical Biochemistry, 2011
- The plant cannabinoid Δ9‐tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in miceBritish Journal of Pharmacology, 2010
- A Medicinal Chemist’s Guide to Molecular InteractionsJournal of Medicinal Chemistry, 2010
- Constitutive activity of cannabinoid‐2 (CB2) receptors plays an essential role in the protean agonism of (+)AM1241 and L768242British Journal of Pharmacology, 2009
- Emerging strategies for exploiting cannabinoid receptor agonists as medicinesBritish Journal of Pharmacology, 2009
- Endocannabinoids and cannabinoid receptors in ischaemia–reperfusion injury and preconditioningBritish Journal of Pharmacology, 2008
- Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic painBritish Journal of Pharmacology, 2008
- CB2 receptor‐mediated migration of immune cells: it can go either wayBritish Journal of Pharmacology, 2008
- Cannabinoid receptors in acute and chronic complications of atherosclerosisBritish Journal of Pharmacology, 2008
- The CB2 cannabinoid agonist AM‐1241 prolongs survival in a transgenic mouse model of amyotrophic lateral sclerosis when initiated at symptom onsetJournal of Neurochemistry, 2007